“…8 We performed 6-FD and RAC-PET studies in patients with MJD to correlate in vivo dopaminergic nigrostriatal function with extrapyramidal features, age of onset, disease duration, disease phenotype, and CAG repeat length. 8 We performed 6-FD and RAC-PET studies in patients with MJD to correlate in vivo dopaminergic nigrostriatal function with extrapyramidal features, age of onset, disease duration, disease phenotype, and CAG repeat length.…”